282 related articles for article (PubMed ID: 37256065)
1. Autophagy in peritoneal fibrosis.
Su HY; Yang JJ; Zou R; An N; Chen XC; Yang C; Yang HJ; Yao CW; Liu HF
Front Physiol; 2023; 14():1187207. PubMed ID: 37256065
[TBL] [Abstract][Full Text] [Related]
2. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
[TBL] [Abstract][Full Text] [Related]
3. Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis.
Shi Y; Hu Y; Wang Y; Ma X; Tang L; Tao M; Qiu A; Zhuang S; Liu N
Front Pharmacol; 2021; 12():724141. PubMed ID: 34497522
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PI3K/AKT/mTOR Signalling Pathway Activates Autophagy and Suppresses Peritoneal Fibrosis in the Process of Peritoneal Dialysis.
Jia M; Qiu H; Lin L; Zhang S; Li D; Jin D
Front Physiol; 2022; 13():778479. PubMed ID: 35309056
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory chemokine (C-C motif) ligand 8 inhibition ameliorates peritoneal fibrosis.
Lee Y; Lee J; Park M; Seo A; Kim KH; Kim S; Kang M; Kang E; Yoo KD; Lee S; Kim DK; Oh KH; Kim YS; Joo KW; Yang SH
FASEB J; 2023 Jan; 37(1):e22632. PubMed ID: 36468785
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin inhibits the expression of fibronectin in human peritoneal mesothelial cells induced by high-glucose peritoneal dialysis solution via SGK1 pathway.
Zhang L; Liu J; Liu Y; Xu Y; Zhao X; Qian J; Sun B; Xing C
Clin Exp Nephrol; 2015 Jun; 19(3):336-42. PubMed ID: 24942605
[TBL] [Abstract][Full Text] [Related]
8. Dimethylaminomicheliolide ameliorates peritoneal fibrosis through the activation of autophagy.
Li S; Peng F; Gong W; Wu J; Wang Y; Xu Z; Liu W; Li H; Yin B; Zhang Y; Chen S; Luo C; Li P; Chen Y; Huang Q; Zhou W; Long H
J Mol Med (Berl); 2019 May; 97(5):659-674. PubMed ID: 30854581
[TBL] [Abstract][Full Text] [Related]
9. STAT3/HIF-1α signaling activation mediates peritoneal fibrosis induced by high glucose.
Yang X; Bao M; Fang Y; Yu X; Ji J; Ding X
J Transl Med; 2021 Jun; 19(1):283. PubMed ID: 34193173
[TBL] [Abstract][Full Text] [Related]
10. Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis.
Xie S; Xu F; Lu Y; Zhang Y; Li X; Yu M; Cui W
Front Pharmacol; 2022; 13():890881. PubMed ID: 35800446
[TBL] [Abstract][Full Text] [Related]
11. High-glucose-based peritoneal dialysis solution induces the upregulation of VEGF expression in human peritoneal mesothelial cells: The role of pleiotrophin.
Liu J; Wu X; Liu Y; Xu Y; Huang Y; Xing C; Wang X
Int J Mol Med; 2013 Nov; 32(5):1150-8. PubMed ID: 24042838
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization.
Zhou X; Chen H; Shi Y; Li J; Ma X; Du L; Hu Y; Tao M; Zhong Q; Yan D; Zhuang S; Liu N
Front Immunol; 2023; 14():1137332. PubMed ID: 36911746
[TBL] [Abstract][Full Text] [Related]
13. Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway.
Bai Y; Wang L; TingYang ; Wang L; Ge W
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2379-2391. PubMed ID: 37052642
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal fibrosis and epigenetic modulation.
Wang Y; Shi Y; Tao M; Zhuang S; Liu N
Perit Dial Int; 2021 Mar; 41(2):168-178. PubMed ID: 32662737
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen and bone morphogenic protein-7 modulate fibrosis and inflammation in the peritoneal fibrosis model developed in uremic rats.
Silva FMO; Costalonga EC; Silva C; Carreira ACO; Gomes SA; Sogayar MC; Fanelli C; Noronha IL
Mol Med; 2019 Aug; 25(1):41. PubMed ID: 31455237
[TBL] [Abstract][Full Text] [Related]
16. Current Insights into Cellular Determinants of Peritoneal Fibrosis in Peritoneal Dialysis: A Narrative Review.
Suryantoro SD; Thaha M; Sutanto H; Firdausa S
J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445436
[TBL] [Abstract][Full Text] [Related]
17. Activation of the RAS contributes to peritoneal fibrosis via dysregulation of low-density lipoprotein receptor.
Liu J; Feng Y; Li N; Shao QY; Zhang QY; Sun C; Xu PF; Jiang CM
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F273-F284. PubMed ID: 33427062
[TBL] [Abstract][Full Text] [Related]
18. The Role of Tyrosine Kinase Receptors in Peritoneal Fibrosis.
Wang L; Zhuang S
Perit Dial Int; 2015; 35(5):497-505. PubMed ID: 26450477
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology and adeno-associated virus-based decorin gene therapy ameliorates peritoneal fibrosis.
Chaudhary K; Moore H; Tandon A; Gupta S; Khanna R; Mohan RR
Am J Physiol Renal Physiol; 2014 Oct; 307(7):F777-82. PubMed ID: 25056353
[TBL] [Abstract][Full Text] [Related]
20. Loss of JNK-Associated Leucine Zipper Protein Promotes Peritoneal Dialysis-Related Peritoneal Fibrosis.
Tian M; Zhang L; Wang Y; Deng M; Peng C; Liang W; Ding G; Shen B; Wang H
Kidney Dis (Basel); 2022 Mar; 8(2):168-179. PubMed ID: 35527988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
